Handok decides to become wholesale dealer again
Handok decides to become wholesale dealer again
Teva has entered into a joint venture with Handok right after separation with Sanofi
  • 고현석 선임기자
  • admin@hkn24.com
  • 승인 2012.12.18 17:36
  • 댓글 0
이 기사를 공유합니다

[SEOUL=Health/medical News] Handok Pharmaceuticals, already in controversy over fairness at the point of being appointed as innovative pharmaceutical company, has at last again decided to be a wholesale dealer for a multinational pharmaceutical company.

Israel's Teva Pharmaceutical Industries has entered into a joint venture with Handok Pharmaceuticals.

Teva will hold 51 percent and Handok will own the rest, in a venture which will be Teva's first in east Asia outside Japan and which is due to start operations in the next few months. Financial details were not disclosed.

Under terms of the deal, Teva will be responsible for manufacturing and supplying medicines, while Handok will handle sales and marketing, distribution and regulatory affairs.

Handok's move is interpreted as another effort to be a wholesale dealer again for foreign capital. Concerns grow both from inside and outside as th company vowed to be opening a new era of independent business when terminating forty-nine-year-long honeymoon relationship with Sanofi. The vow has turned out to be just a vain declaration.

At Handok's temporary shareholders meeting 14 Dec, shareholders pointed out the pathetic situation where the company had to sell other drug makers' product without investing meoney into research and development.   

A shareholder said, "handok has been only selling Sanofi's products while Handok should have developed its own products. Although the company is running a research lab, it actually did not develop any new product own its own. I urge the company to focus on research and development from now on."

An official from pharmaceutical industry said, "The purpose for the introduction of innovative pharmaceutical companies is to stimulate and encourage the drug makers capable of developing new drugs. The government should appoint the companies truly willing to develop new drugs."

The comment can be translated into a criticism toward Handok's move heavily gravitated to being wholesale dealer's function.

Some industry observers put out an analysis that Handok Pharmaceuticals has changed its company name into simply 'Handok' without 'pharmaceuticals'in an effort to expand its business to various business spheres. 

-대한민국 의학전문지 헬스코리아뉴스-



댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

      • 회사명 : (주)헬코미디어
      • 서울특별시 마포구 매봉산로2길 45, 302호(상암동, 해나리빌딩)
      • 대표전화 : 02-364-2002
      • 청소년보호책임자 : 이슬기
      • 제호 : 헬스코리아뉴스
      • 발행일 : 2007-01-01
      • 등록번호 : 서울 아 00717
      • 재등록일 : 2008-11-27
      • 발행인 : 임도이
      • 편집인 : 이순호
      • 헬스코리아뉴스에서 발행하는 모든 저작물(컨텐츠, 기사)는 저작권법의 보호를 받는 바, 무단·전재·복제·배포 등을 금합니다.
      • 「열린보도원칙」 당 매체는 독자와 취재원 등 뉴스이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고
        있음을 알려드립니다. 고충처리인 이슬기 02-364-2002 webmaster@hkn24.com
      • Copyright © 2024 헬스코리아뉴스. All rights reserved. mail to admin@hkn24.com
      ND소프트
      편집자 추천 뉴스
      베스트 클릭